RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667 · see citing works

Interleukin-10-deficient mice develop chronic enterocolitis

Kühn, R., Löhler, J., Rennick, D. M., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,248 · see citing works

Diabetes and cardiovascular disease. The Framingham study

Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.241.19.2035 · Cited by 3,958 · see citing works

RAGE Mediates a Novel Proinflammatory Axis

Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80801-6 · Cited by 1,864 · see citing works

Periodontal Disease: The sixth complication of diabetes mellitus

Löe, H. A. (1993) · Diabetes Care · doi:10.2337/diacare.16.1.329 · Cited by 1,585 · see citing works

S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles

Donato, R. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00046-2 · Cited by 1,580 · see citing works

Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.

Neeper, M. P., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y., Elliston, K. O., Stern, D., & SHAW, A. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,542 · see citing works

Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins

Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y., Pinsky, D. J., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,305 · see citing works

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

Schmidt, A. M., Yan, S. D., Yan, S. F., & Stern, D. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14002 · Cited by 1,256 · see citing works

The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin

Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151 · see citing works

Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor

Ishii, H., Jirousek, M. R., Koya, D., Takagi, C., Xia, P., Clermont, A. C., Bursell, S., Kern, T. S., Ballas, L. M., Heath, W. F., et al. (1996) · Science · doi:10.1126/science.272.5262.728 · Cited by 1,103 · see citing works

Structure Elucidation of a Senescence Cross-Link from Human Extracellular Matrix

Sell, D. R., & Monnier, V. M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)88225-8 · Cited by 1,082 · see citing works

Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein.

Ahmed, M. U., Thorpe, S. R., & Baynes, J. W. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89188-3 · Cited by 864 · see citing works

Diabetes-Associated Sustained Activation of the Transcription Factor Nuclear Factor-κB

Bierhaus, A., Schiekofer, S., Schwaninger, M., Andrassy, M., Humpert, P. M., Chen, J., Hong, M., Luther, T., Henle, T., Klöting, I., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2792 · Cited by 826 · see citing works

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

Schleicher, E. D., Wagner, E., & Nerlich, A. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119180 · Cited by 714 · see citing works

A Prospective Study of Maturity-Onset Diabetes Mellitus and Risk of Coronary Heart Disease and Stroke in Women

Manson, J. E. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400060077013 · Cited by 675 · see citing works

Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats.

Wautier, J., Zoukourian, C., Chappey, O., Wautier, M.-P., Guillausseau, P.-J., Cao, R. Y., Hori, O., Stern, D., & Schmidt, A. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118397 · Cited by 551 · see citing works

Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo

Dyer, D. G., Blackledge, J. A., Thorpe, S. R., & Baynes, J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99007-1 · Cited by 535 · see citing works

Characterization and Functional Analysis of the Promoter of RAGE, the Receptor for Advanced Glycation End Products

Li, J., & Schmidt, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16498 · Cited by 525 · see citing works

N.epsilon.-(Carboxymethyl)lysine Is a Dominant Advanced Glycation End Product (AGE) Antigen in Tissue Proteins

Reddy, S., Bichler, J., Wells‐Knecht, K. J., Thorpe, S. R., & Baynes, J. (1995) · Biochemistry · doi:10.1021/bi00034a021 · Cited by 524 · see citing works

Expression of Advanced Glycation End Products and Their Cellular Receptor RAGE in Diabetic Nephropathy and Nondiabetic Renal Disease

Tanji, N., Markowitz, G. S., Fu, C., Kislinger, T., Taguchi, A., Pischetsrieder, M., Stern, D. M., Schmidt, A. M., & D’Agati, V. D. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1191656 · Cited by 485 · see citing works

Characterization of the Mechanism for the Chronic Activation of Diacylglycerol-Protein Kinase C Pathway in Diabetes and Hypergalactosemia

Xia, P., Inoguchi, T., Kern, T. S., Engerman, R. L., Oates, P. J., & King, G. L. (1994) · Diabetes · doi:10.2337/diab.43.9.1122 · Cited by 476 · see citing works

Nε-(Carboxymethyl)lysine Protein Adduct Is a Major Immunological Epitope in Proteins Modified with Advanced Glycation End Products of the Maillard Reaction

Ikeda, K., Higashi, T., Sano, H., Jinnouchi, Y., Yoshida, M., Araki, T., Ueda, S., & Horiuchi, S. (1996) · Biochemistry · doi:10.1021/bi9530550 · Cited by 434 · see citing works

Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.

Horie, K., Miyata, T., Maeda, K., Miyata, S., Sugiyama, S., Sakai, H., van Ypersole de Strihou, C., Monnier, V. M., Witztum, J. L., & Kurokawa, K. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119853 · Cited by 433 · see citing works

Prevalence of Periodontal Disease in Insulin-Dependent Diabetes Mellitus (Juvenile Diabetes)

Cianciola, L. J., Park, B. H., Bruck, E., Mosovich, L. L., & Genco, R. J. (1982) · The Journal of the American Dental Association · doi:10.14219/jada.archive.1982.0240 · Cited by 396 · see citing works

Type 2 Diabetes Mellitus and Periodontal Disease

Shlossman, M., Knowler, W. C., Pettitt, D. J., & Genco, R. J. (1990) · The Journal of the American Dental Association · doi:10.14219/jada.archive.1990.0211 · Cited by 368 · see citing works

Coronary heart disease in young Type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors

Jensen, T., Borch‐Johnsen, K., Kofoed‐Enevoldsen, A., & Deckert, T. (1987) · Diabetologia · doi:10.1007/bf00274218 · Cited by 364 · see citing works

The myeloperoxidase system of human phagocytes generates Nε-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation

Anderson, M. M., Requena, J. R., Crowley, J. R., Thorpe, S. R., & Heinecke, J. W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3042 · Cited by 349 · see citing works

Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis

Yan, S. D., Zhu, H., Zhu, A., Golabek, A., Du, H., Roher, A., Yu, J., Soto, C., Schmidt, A. M., Stern, D., et al. (2000) · Nature Medicine · doi:10.1038/76216 · Cited by 343 · see citing works

Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins.

Li, Y. M., Mitsuhashi, T., Wojciechowicz, D. C., Shimizu, N., Li, J., Stitt, A. W., He, C., Banerjee, D., & Vlassara, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11047 · Cited by 340 · see citing works

The Role of Growth Factors in Wound Healing

Greenhalgh, D. G. (1996) · doi:10.1097/00005373-199607000-00029 · Cited by 328 · see citing works

Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: A twenty-three year follow-up study

Messent, J. W. C., Elliott, T. G., Hill, R. D., Jarrett, R. J., KEEN, H., & Viberti, G. (1992) · Kidney International · doi:10.1038/ki.1992.128 · Cited by 327 · see citing works

Requirement for p38 and p44/p42 Mitogen-Activated Protein Kinases in RAGE-Mediated Nuclear Factor-κB Transcriptional Activation and Cytokine Secretion

Yeh, C.-H., Sturgis, L., Haidacher, J., Zhang, X.-N., Sherwood, S. J., Bjercke, R. J., Juhasz, O., Crow, M. T., Tilton, R. G., & Denner, L. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1495 · Cited by 326 · see citing works

Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells.

Yerneni, K. K. V., Bai, W., Khan, B. V., Medford, R. M., & Natarajan, R. D. (1999) · Diabetes · doi:10.2337/diabetes.48.4.855 · Cited by 321 · see citing works

Pentosidine Formation in Skin Correlates With Severity of Complications in Individuals With Long-Standing IDDM

Sell, D. R., Lapolla, A., Odetti, P. R., Fogarty, J. F., & Monnier, V. M. (1992) · Diabetes · doi:10.2337/diab.41.10.1286 · Cited by 310 · see citing works

Age-dependent accumulation of N.epsilon.-(carboxymethyl)lysine and N.epsilon.-(carboxymethyl)hydroxylysine in human skin collagen

Dunn, J. A., McCance, D. R., Thorpe, S. R., Lyons, T. J., & Baynes, J. (1991) · Biochemistry · doi:10.1021/bi00219a007 · Cited by 304 · see citing works

Advanced glycation endproducts (AGEs) induce oxidant stress in the gingiva: a potential mechanism underlying accelerated periodontal disease associated with diabetes

Schmidt, A. M., Weidman, E., Lalla, E., Yan, S. D., Hori, O., Cao, R. Y., Brett, J. G., & Lamster, I. B. (1996) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.1996.tb01417.x · Cited by 304 · see citing works

5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects.

Uusitupa, M. I. J., NISKANEN, L. K., Siitonen, O., Voutilainen, E., & Pyörälà, K. (1990) · Circulation · doi:10.1161/01.cir.82.1.27 · Cited by 289 · see citing works

Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation.

Parkkinen, J., Raulo, E., Merenmies, J. M., Nolo, R. M., Kajander, E. O., Baumann, M., & Rauvala, H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36575-5 · Cited by 216 · see citing works

Isolation and some characteristics of an adhesive factor of brain that enhances neurite outgrowth in central neurons.

Rauvala, H., & Pihlaskari, R. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)49302-7 · Cited by 211 · see citing works

Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues

Inoguchi, T., Xia, P., Kunisaki, M., Higashi, S., Feener, E. P., & King, G. L. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.267.3.e369 · Cited by 189 · see citing works

Wound healing and the diabetic patient.

Goodson, W. H., & Tk, H. (1979) · PubMed · Cited by 177 · see citing works

Clinical efficacy of becaplermin (rhPDGF-BB) gel

Wieman, T. J. (1998) · The American Journal of Surgery · doi:10.1016/s0002-9610(98)00185-8 · Cited by 162 · see citing works

Recombinant human platelet‐derived growth factor‐BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open‐label clinical evaluation of efficacy

Embil, J. M., Papp, K. A., Sibbald, G. R., Tousignant, J., Smiell, J. M., Wong, B. Y. L., Lau, C., & THE CANADIAN BECAPLERMIN STUDY GROUP (2000) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.2000.00162.x · Cited by 161 · see citing works

The dark side of glucose

Schmidt, A. M., Yan, S. D., & Stern, D. M. (1995) · Nature Medicine · doi:10.1038/nm1095-1002 · Cited by 150 · see citing works

Wound Healing in Diabetes Mellitus

Morain, W. D., & Colen, L. B. (1990) · Clinics in Plastic Surgery · doi:10.1016/s0094-1298(20)30624-6 · Cited by 145 · see citing works

High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-ϰB-dependent

Park, C. W., Kim, J., Lee, J. W., Kim, Y. S., Ahn, H. J., Shin, Y. S., Kim, S.-Y., Choi, E. J., Chang, Y. S., & Bang, B. K. (2000) · Diabetologia · doi:10.1007/s001250051567 · Cited by 138 · see citing works

High-glucose-induced nuclear factor κB activation in vascular smooth muscle cells

Hattori, Y. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00425-3 · Cited by 112 · see citing works

The adhesive and neurite-promoting molecule p30: analysis of the amino-terminal sequence and production of antipeptide antibodies that detect p30 at the surface of neuroblastoma cells and of brain neurons.

Rauvala, H., Merenmies, J. M., Pihlaskari, R., Korkolainen, M., Huhtala, M.-L., & Panula, P. (1988) · The Journal of Cell Biology · doi:10.1083/jcb.107.6.2293 · Cited by 96 · see citing works

A murine model of accelerated periodontal disease in diabetes

Lalla, E., Lamster, I. B., Feit, M., Huang, L., & Schmidt, A. M. (1998) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.1998.tb02335.x · Cited by 95 · see citing works

Increased Transcapillary Escape Rate of Albumin in Microalbuminuric Type II Diabetic Patients

Nannipieri, M., Rlzzo, L., Rapuano, A., PILO, A., Penno, G., & Navalesi, R. (1995) · Diabetes Care · doi:10.2337/diacare.18.1.1 · Cited by 88 · see citing works

Sp1-binding Elements in the Promoter of RAGE Are Essential for Amphoterin-mediated Gene Expression in Cultured Neuroblastoma Cells

Li, J., Qu, X., & Schmidt, A. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.30870 · Cited by 82 · see citing works

The myeloic related protein MRP8/14 (27E10 antigen)— usefulness as a potential marker for disease activity in ulcerative colitis and putative biological function

Lügering, N., Stoll, R., Schmid, K. W., Kucharzik, T. F., Stein, H., BURMEISTER, G., Sorg, C., & Domschke, W. (1995) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1995.tb01982.x · Cited by 75 · see citing works

Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brain

Takeda, A., Yasuda, T., Miyata, T., Mizuno, K., Li, M., YONEYAMA, S., Horie, K., Maeda, K., & Sobue, G. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13275-4 · Cited by 62 · see citing works

Demonstration of novel anti-arthritic and anti-inflammatory effects of diphosphonates.

Dunn, C. J., Galinet, L. A., Wu, H., Nugent, R. A., Schlachter, S. T., Staite, N. D., Aspar, D. G., Elliott, G. A., Essani, N. A., & Rohloff, N. A. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39487-5 · Cited by 62 · see citing works

Suppression of accelerated diabetic atherosclerosis by soluble receptor for age (srage)

Schmidt, A. M. (1998) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(98)80038-3 · Cited by 53 · see citing works

Sterile inflammation: sensing and reacting to damage

Chen, G. Y., & Nuñez, G. (2010) · Nature Reviews Immunology · doi:10.1038/nri2873 · Cited by 3,051 · see citing works

Macrophages, inflammation, and insulin resistance

Olefsky, J. M., & Glass, C. K. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135846 · Cited by 2,733 · see citing works

Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury

Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261 · see citing works

Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein

Park, J. S., Svetkauskaite, D., He, Q., Kim, J., Strassheim, D., Ishizaka, A., & Abraham, E. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306793200 · Cited by 1,560 · see citing works

Understanding RAGE, the receptor for advanced glycation end products

Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M., & Nawroth, P. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0688-7 · Cited by 1,297 · see citing works

Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs

Twarda‐Clapa, A., Olczak, A., Białkowska, A. M., & Koziołkiewicz, M. (2022) · Cells · doi:10.3390/cells11081312 · Cited by 792 · see citing works

S100A8 and S100A9 in inflammation and cancer

Gebhardt, C., Németh, J., Angel, P., & Hess, J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.05.017 · Cited by 696 · see citing works

Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins

Casserly, I., & Topol, E. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15900-x · Cited by 560 · see citing works

Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease

Srikanth, V., Maczurek, A., Phan, T., Steele, M., Westcott, B., Juskiw, D., & Münch, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.016 · Cited by 524 · see citing works

Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms

Stirban, A. O., Gawlowski, T., & Roden, M. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.11.006 · Cited by 365 · see citing works

RAGE-mediated signaling contributes to intraneuronal transport of amyloid-β and neuronal dysfunction

Takuma, K., Fang, F., Zhang, W., Yan, S., Fukuzaki, E., Du, H., Sosunov, A., McKhann, G., Funatsu, Y., Nakamichi, N., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905686106 · Cited by 290 · see citing works

Lipoic acid as a novel treatment for Alzheimer's disease and related dementias

Holmquist, L., Stuchbury, G., Berbaum, K., Muscat, S., Young, S. A., Häger, K., Engel, J., & Münch, G. W. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.07.001 · Cited by 286 · see citing works

Receptor for Advanced Glycation End Products Is Subjected to Protein Ectodomain Shedding by Metalloproteinases

Zhang, L., Bukulin, M., Kojro, E., Roth, A., Metz, V. V., Fahrenholz, F., Nawroth, P. P., Bierhaus, A., & Postina, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806948200 · Cited by 285 · see citing works

S100P Stimulates Cell Proliferation and Survival via Receptor for Activated Glycation End Products (RAGE)

Arumugam, T., Simeone, D. M., Schmidt, A. M., & Logsdon, C. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310124200 · Cited by 269 · see citing works

Uremic Toxicity of Advanced Glycation End Products in CKD

Stinghen, A. E. M., Massy, Z. A., Vlassara, H., Striker, G. E., & Boullier, A. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014101047 · Cited by 243 · see citing works

Macrophage endocytosis of high-mobility group box 1 triggers pyroptosis

Xu, J., Jiang, Y., Wang, J., Shi, X., Liu, Q., Liu, Z., Li, Y., Scott, M. J., Xiao, G., Li, S., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2014.40 · Cited by 239 · see citing works

The receptor RAGE: Bridging inflammation and cancer

Riehl, A., Németh, J., Angel, P. E., & Heß, J. (2009) · Cell Communication and Signaling · doi:10.1186/1478-811x-7-12 · Cited by 236 · see citing works

Chapter 4 Fibroblasts—A Diverse Population at the Center of It All

Sorrell, J. M., & Caplan, A. I. (2009) · International review of cytology · doi:10.1016/s1937-6448(09)76004-6 · Cited by 227 · see citing works

Circulating Levels of Soluble Receptor for Advanced Glycation End Products in Alzheimer Disease and Vascular Dementia

Emanuele, E., D’Angelo, A., Tomaino, C., Binetti, G. G., Ghidoni, R., Politi, P., Bernardi, L., Maletta, R., Bruni, A. C., & Geroldi, D. (2005) · Archives of Neurology · doi:10.1001/archneur.62.11.1734 · Cited by 220 · see citing works

Advanced Glycation End Products Enhance Expression of Pro-apoptotic Genes and Stimulate Fibroblast Apoptosis through Cytoplasmic and Mitochondrial Pathways

Alikhani, Z., Alikhani, M., Boyd, C. M., Nagao, K., Trackman, P. C., & Graves, D. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406313200 · Cited by 215 · see citing works

Advanced glycation end products: role in pathology of diabetic cardiomyopathy

Bodiga, V. L., Eda, S. R., & Bodiga, S. (2013) · Heart Failure Reviews · doi:10.1007/s10741-013-9374-y · Cited by 207 · see citing works

Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases

Maillard-Lefebvre, H., Boulanger, E., Daroux, M., Gaxatte, C., Hudson, B. I., & Lambert, M. (2009) · Rheumatology · doi:10.1093/rheumatology/kep199 · Cited by 190 · see citing works

Regulation of osteoclast function and bone mass by RAGE

Zhou, Z., Immel, D., Xi, C.-X., Bierhaus, A., Feng, X., Mei, L., Nawroth, P., Stern, D. M., & Xiong, W.-C. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051947 · Cited by 178 · see citing works

Advanced Glycation End Products Enhance Macrophages Polarization into M1 Phenotype through Activating RAGE/NF-κB Pathway

Jin, X., Yao, T., Zhou, Z., Zhu, J., Zhang, S., Hu, W., & Shen, C. (2015) · BioMed Research International · doi:10.1155/2015/732450 · Cited by 173 · see citing works

HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation

Nogueira‐Machado, J. A., Volpe, C. M. O., Veloso, C. A., & Chaves, M. M. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.575360 · Cited by 168 · see citing works

Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection

Lutterloh, E. C., Opal, S. M., Pittman, D. D., Keith, J. C., Tan, X., Clancy, B. M., Palmer, H. S., Milarski, K. L., Sun, Y., Palardy, J. E., et al. (2007) · Critical Care · doi:10.1186/cc6184 · Cited by 169 · see citing works

Advanced glycation end products mediated cellular and molecular events in the pathology of diabetic nephropathy

Kumar Pasupulati, A., Chitra, P. S., & Reddy, G. B. (2016) · Biomolecular Concepts · doi:10.1515/bmc-2016-0021 · Cited by 163 · see citing works

PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease

Sabbagh, M. N., Agro, A., Bell, J. S., Aisen, P. S. S., Schweizer, E. E., & Galasko, D. R. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318204b550 · Cited by 161 · see citing works

Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes

Tan, K. C. B., Shiu, S. W. M., Chow, W. S., Leng, L., Bucala, R., & Betteridge, D. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0394-1 · Cited by 159 · see citing works

Pathologies Involving the S100 Proteins and Rage

Heizmann, C. W., Ackermann, G. E., & Galichet, A. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6191-2_5 · Cited by 160 · see citing works

Emerging role of advanced glycation-end products (AGEs) in the pathobiology of eye diseases

Kandarakis, S., Piperi, C., Topouzis, F., & Papavassiliou, A. G. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.05.002 · Cited by 159 · see citing works

Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays

Hsieh, H.-L., Schäfer, B. W., Sasaki, N., & Heizmann, C. W. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01190-2 · Cited by 151 · see citing works

Advanced Glycation End Products and Their Effect on Vascular Complications in Type 2 Diabetes Mellitus

Lee, J., Yun, J., & Ko, S. (2022) · Nutrients · doi:10.3390/nu14153086 · Cited by 155 · see citing works

Aβ-induced formation of autophagosomes is mediated by RAGE-CaMKKβ-AMPK signaling

Son, S. M., Jung, E. S., Shin, H. J., Byun, J., & Mook‐Jung, I. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.039 · Cited by 140 · see citing works

Disordered osteoclast formation in RAGE-deficient mouse establishes an essential role for RAGE in diabetes related bone loss

Ding, K.-H., Wang, Z.-Z., Hamrick, M. W., Deng, Z.-B., Zhou, L., Kang, B., Yan, S.-L., She, J., Stern, D. M., Isales, C. M., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.107 · Cited by 140 · see citing works

RAGE: A Multi-Ligand Receptor Unveiling Novel Insights in Health and Disease

Alexiou, P., Chatzopoulou, M., Pegklidou, K., & Demopoulos, V. J. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791331086 · Cited by 138 · see citing works

Thiazolidinediones Reduce Endothelial Expression of Receptors for Advanced Glycation End Products

Marx, N., Walcher, D., Ivanova, N., Rautzenberg, K., Jung, A., Friedl, R., Hombach, V., Caterina, R. D., Basta, G., Wautier, M., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2662 · Cited by 137 · see citing works

Metabolism addiction in pancreatic cancer

Blum, R., & Kloog, Y. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.38 · Cited by 134 · see citing works

Advanced Glycation End Products and Risks for Chronic Diseases: Intervening Through Lifestyle Modification

Prasad, C., Davis, K. E., Imrhan, V., Juma, S., & Vijayagopal, P. (2017) · American Journal of Lifestyle Medicine · doi:10.1177/1559827617708991 · Cited by 134 · see citing works

Vimentin Is the Specific Target in Skin Glycation

Kueper, T., Grune, T., Prahl, S., Lenz, H., Welge, V., Biernoth, T., Vogt, Y., Muhr, G., Gaemlich, A., Jung, T., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701586200 · Cited by 133 · see citing works

Toxic Advanced Glycation End Products (TAGE) Theory in Alzheimer’s Disease

Sato, T., Shimogaito, N., Wu, X., Kikuchi, S., Yamagishi, S., & Takeuchi, M. (2006) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317506289277 · Cited by 133 · see citing works

Receptor for advanced glycation end products and age-related macular degeneration

Howes, K. A., Liu, Y., Dunaief, J. L., Milam, A., Frederick, J. M., Marks, A., & Baehr, W. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0404 · Cited by 131 · see citing works

The Clinical Relevance of Advanced Glycation Endproducts (AGE) and Recent Developments in Pharmaceutics to Reduce AGE Accumulation

Smit, A. J., & Lutgers, H. L. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043364342 · Cited by 130 · see citing works

Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling

Sousa, M. M., & Saraiva, M. J. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.11.002 · Cited by 129 · see citing works

Uncoupling the Roles of HLA-DRB1 and HLA-DRB5 Genes in Multiple Sclerosis

Caillier, S. J., Briggs, F. B. S., Cree, B., Baranzini, S. E., Fernández-Viña, M., Ramsay, P. P., Khan, O. A., Royal, W., Hauser, S. L., Barcellos, L. F., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5473 · Cited by 126 · see citing works

The Discovery of Glycated Hemoglobin: A Major Event in the Study of Nonenzymatic Chemistry in Biological Systems

Rahbar, S. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.002 · Cited by 126 · see citing works

Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis

Chen, Y.-S., Yan, W., Geczy, C. L., Brown, M. A., & Thomas, R. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2645 · Cited by 119 · see citing works

Evaluation of rage isoforms, ligands, and signaling in the brain

Ding, Q., & Keller, J. N. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.08.006 · Cited by 119 · see citing works

In Skeletal Muscle Advanced Glycation End Products (AGEs) Inhibit Insulin Action and Induce the Formation of Multimolecular Complexes Including the Receptor for AGEs

Cassese, A., Esposito, I., Fiory, F., Barbagallo, A., Paturzo, F., Mirra, P., Ulianich, L., Giacco, F., Iadicicco, C., Lombardi, A., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801698200 · Cited by 116 · see citing works

Soluble receptor for advanced glycation end products triggers a proinflammatory cytokine cascade via β2 integrin Mac‐1

Pullerits, R., Brisslert, M., Jonsson, I., & Tarkowski, A. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22217 · Cited by 115 · see citing works

Peptide and amino acid glycation: new insights into the Maillard reaction

Horvat, Š., & Jakas, A. (2003) · Journal of Peptide Science · doi:10.1002/psc.519 · Cited by 114 · see citing works

Mechanisms for the induction of HNE- MDA- and AGE-adducts, RAGE and VEGF in retinal pigment epithelial cells.

Zhou, J., Cai, B., Jang, Y. P., Pachydaki, S., Schmidt, A. M., & Sparrow, J. R. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2004.11.009 · Cited by 113 · see citing works

Autoimmunity in Alzheimer’s disease: increased levels of circulating IgGs binding Aβ and RAGE peptides

Mruthinti, S., Buccafusco, J. J., Hill, W., Waller, J. L., Jackson, T. W., ZAMRINI, E. Y., & Schade, R. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.11.001 · Cited by 113 · see citing works

Serum advanced glycation end products (AGEs) are associated with insulin resistance

Tan, K. C. B., Shiu, S. W. M., Wong, Y., & Tam, X. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1188 · Cited by 111 · see citing works

Altered regulation of the PINK1 locus: a link between type 2 diabetes and neurodegeneration?

Scheele, C., Nielsen, A. R., Walden, T. B., Sewell, D. A., Fischer, C. P., Brogan, R. J., Petrovic, N., Larsson, O., Tesch, P. A., Wennmalm, K., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8520com · Cited by 110 · see citing works

Advanced Glycation End Products (AGEs) and Chronic Kidney Disease: Does the Modern Diet AGE the Kidney?

Fotheringham, A. K., Gallo, L. A., Borg, D. J., & Forbes, J. M. (2022) · Nutrients · doi:10.3390/nu14132675 · Cited by 112 · see citing works

RAGE and amyloid beta interactions: Atomic force microscopy and molecular modeling

Chaney, M. O., Stine, W. B., Kokjohn, T. A., Kuo, Y., Esh, C. L., Rahman, A., Luehrs, D. C., Schmidt, A. M., Stern, D. M., Yan, S. D., et al. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.03.014 · Cited by 109 · see citing works

HMGB1 in Sepsis

Andersson, U., & Tracey, K. J. (2003) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310016286 · Cited by 108 · see citing works

RAGE Expression and ROS Generation in Neurons: Differentiation versus Damage

Piras, S., Furfaro, A. L., Domenicotti, C., Traverso, N., Marinari, U. M., Pronzato, M. A., & Nitti, M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9348651 · Cited by 104 · see citing works

Signal transduction pathways in mouse microglia N‐11 cells activated by advanced glycation endproducts (AGEs)

Dukić-Stefanović, S., Gasic‐Milenkovic, J., Deuther‐Conrad, W., & Münch, G. W. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01988.x · Cited by 104 · see citing works

Autocrine S100B effects on astrocytes are mediated via RAGE

Ponath, G. D., Schettler, C., Kaestner, F., Voigt, B., WENTKER, D., Arolt, V., & Rothermundt, M. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.12.011 · Cited by 104 · see citing works

Advanced Glycation End Products Play Adverse Proinflammatory Activities in Osteoporosis

Sanguineti, R., Puddu, A., Mach, F., Montecucco, F., & Viviani, G. L. (2014) · Mediators of Inflammation · doi:10.1155/2014/975872 · Cited by 103 · see citing works

Mechanisms of obesity- and diabetes mellitus-related pancreatic carcinogenesis: a comprehensive and systematic review

Ruze, R., Song, J., Yin, X., Chen, Y., Xu, R., Wang, C., & Zhao, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01376-w · Cited by 103 · see citing works

Upregulation of RAGE and its ligands in proliferative retinal disease

Pachydaki, S. I., Tari, S. R., Lee, S. E., Ma, W., Tseng, J., Sosunov, A. A., Cataldergirmen, G., Scarmeas, N., Caspersen, C. S., Chang, S., et al. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.09.022 · Cited by 101 · see citing works

Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1

DeMarco, R., Fink, M. P., & Lotze, M. T. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.07.023 · Cited by 99 · see citing works

The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome

Guo, W. A., Knight, P. R., & Raghavendran, K. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2624-y · Cited by 97 · see citing works

Advanced glycation end products and diabetic retinopathy

Milne, R. W., & Brownstein, S. (2011) · Amino Acids · doi:10.1007/s00726-011-1071-3 · Cited by 96 · see citing works

Tissue damage negatively regulates LPS-induced macrophage necroptosis

Li, Z. A., Scott, M. J., Fan, E., Li, Y., Liu, J., Xiao, G., Li, S., Billiar, T. R., Wilson, M. A., Jiang, Y., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.21 · Cited by 96 · see citing works

Involvement of the Toxic AGEs (TAGE)-RAGE System in the Pathogenesis of Diabetic Vascular Complications: A Novel Therapeutic Strategy

Takeuchi, M., Takino, J.-I., & Yamagishi, S. (2010) · Current Drug Targets · doi:10.2174/1389450111009011468 · Cited by 95 · see citing works

Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products

Mone, M. D., Koehne, C., Rediske, J. J., Hughes, T. E., & Valencia, J. (2004) · Diabetologia · doi:10.1007/s00125-004-1392-9 · Cited by 94 · see citing works

Posttranslationally Modified Proteins as Mediators of Sustained Intestinal Inflammation

Andrassy, M., Igwe, J. C., Autschbach, F., Volz, C., Remppis, A. B., Neurath, M. F., Schleicher, E. D., Humpert, P. M., Wendt, T., Liliensiek, B., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050713 · Cited by 94 · see citing works

Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes

Tan, K. C. B., Chow, W.-S., Tso, A. W. K., Xu, A., Tse, H., Hoo, R. L. C., Betteridge, D. J., & Lam, K. S. L. (2007) · Diabetologia · doi:10.1007/s00125-007-0759-0 · Cited by 91 · see citing works

Divergent Pathways of Gene Expression Are Activated by the RAGE Ligands S100b and AGE-BSA

Valencia, J., Mone, M. D., Zhang, J., Weetall, M. L., Buxton, F. P., & Hughes, T. E. (2004) · Diabetes · doi:10.2337/diabetes.53.3.743 · Cited by 91 · see citing works

Extracellular HSP70 Activates ERK1/2, NF-kB and Pro-Inflammatory Gene Transcription Through Binding with RAGE in A549 Human Lung Cancer Cells

Somensi, N., Brum, P. O., Ramos, V. D. M., Gasparotto, J., Zanotto‐Filho, A., Rostirolla, D. C., Morrone, M. D. S., Moreira, J. C. F., & Gelain, D. P. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000480213 · Cited by 89 · see citing works

Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes

Tam, X., Shiu, S. W. M., Leng, L., Bucala, R., Betteridge, D. J., & Tan, K. C. B. (2010) · Clinical Science · doi:10.1042/cs20100256 · Cited by 89 · see citing works

Calcium-binding protein S100P and cancer: mechanisms and clinical relevance

Jiang, H., Hu, H., Tong, X., Jiang, Q., Zhu, H., & Zhang, S. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1062-5 · Cited by 89 · see citing works

Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes

Tam, H., Shiu, S. W. M., Wong, Y. M., Chow, W.-S., Betteridge, D. J., & Tan, K. C. B. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.08.031 · Cited by 79 · see citing works

Elevation of Nε-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis

Yagmur, E., Tacke, F., Weiß, C., Lahme, B., Manns, M. P., Kiefer, P., Trautwein, C., & Gressner, A. M. (2005) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2005.07.016 · Cited by 78 · see citing works

Splice variants of the receptor for advanced glycosylation end products (RAGE) in human brain

Ding, Q., & Keller, J. N. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.09.059 · Cited by 77 · see citing works

From hyperglycemia to AGE-RAGE interaction on the cell surface: A dangerous metabolic route for diabetic patients

Nogueira‐Machado, J. A., & Chaves, M. M. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.7.871 · Cited by 74 · see citing works

The AGE-RAGE Axis and RAGE Genetics in Chronic Obstructive Pulmonary Disease

Sharma, A., Kaur, S., Sarkar, M. S., Sarin, B., & Changotra, H. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08815-4 · Cited by 71 · see citing works

Diabetic Complications: An Update on Pathobiology and Therapeutic Strategies

Nellaiappan, K., Preeti, K., Khatri, D. K., & Singh, S. B. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210309104203 · Cited by 71 · see citing works

MAPK, β-amyloid and synaptic dysfunction: the role of RAGE

Origlia, N., Arancio, O., Domenici, L., & Yan, S. S. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.107 · Cited by 70 · see citing works

Precursor of Advanced Glycation End Products Mediates ER-Stress-Induced Caspase-3 Activation of Human Dermal Fibroblasts through NAD(P)H Oxidase 4

Loughlin, D. T., & Artlett, C. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011093 · Cited by 69 · see citing works

Novel inhibitors of glycation and AGE formation

Rahbar, S. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0021-x · Cited by 69 · see citing works

Transamidation by Transglutaminase 2 Transforms S100A11 Calgranulin into a Procatabolic Cytokine for Chondrocytes

Cecil, D. L., & Terkeltaub, R. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.8378 · Cited by 68 · see citing works

Trientine Reduces BACE1 Activity and Mitigates Amyloidosis <i>via</i> the AGE/RAGE/NF-κB Pathway in a Transgenic Mouse Model of Alzheimer's Disease

Wang, C.-Y., Xie, J.-W., Xu, Y., Wang, T., Cai, J.-H., Wang, X., Zhao, B.-L., An, L., & Wang, Z.-Y. (2013) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2012.5158 · Cited by 66 · see citing works

Association of RAGE gene polymorphisms with type 2 diabetes mellitus, diabetic retinopathy and diabetic nephropathy

Kang, P., Tian, C., & Jia, C. (2012) · Gene · doi:10.1016/j.gene.2012.03.056 · Cited by 66 · see citing works

Age associated changes of AGE-receptor expression: RAGE upregulation is associated with human heart dysfunction

Simm, A., Caßelmann, C. A., Schubert, A., Hofmann, S., Reimann, A., & Silber, R. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2003.12.006 · Cited by 65 · see citing works

Multivalent glycans for biological and biomedical applications

Kim, Y., Hyun, J. Y., & Shin, I. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01606c · Cited by 64 · see citing works

Advanced glycation endproducts mediate pro-inflammatory actions in human gestational tissues via nuclear factor-κB and extracellular signal-regulated kinase 1/2

Lappas, M., Permezel, M., & Rice, G. E. (2007) · Journal of Endocrinology · doi:10.1677/joe-06-0081 · Cited by 64 · see citing works

RAGE-NF-?B pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy

Macaione, V., Aguennouz, M., Rodolico, C., Mazzeo, A. T., Patti, A., Cannistraci, E., Colantone, L., Giorgio, R. M. D., Luca, G. D., & Vita, G. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00724.x · Cited by 63 · see citing works

Receptor for Advanced Glycation End Products Facilitates Host Defense duringEscherichia coli–Induced Abdominal Sepsis in Mice

van Zoelen, M. A. D., Schmidt, A., Florquin, S., Meijers, J. C. M., de Beer, R., de Vos, A. F., Nawroth, P. P., Bierhaus, A., & van der Poll, T. (2009) · The Journal of Infectious Diseases · doi:10.1086/604730 · Cited by 63 · see citing works

Statins stimulate the production of a soluble form of the receptor for advanced glycation end products

Quade-Lyssy, P., Kanarek, A. M., Baiersdörfer, M., Postina, R., & Kojro, E. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m038968 · Cited by 62 · see citing works

Alternative routes for the formation of glyceraldehyde-derived AGEs (TAGE) in vivo

Takeuchi, M., & Yamagishi, S. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.03.005 · Cited by 62 · see citing works

Induction of RAGE Shedding by Activation of G Protein-Coupled Receptors

Metz, V. V., Kojro, E., Rat, D., & Postina, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041823 · Cited by 61 · see citing works

Enzyme Inhibition and Bioapplications

Sharma, R. (2012) · InTech eBooks · doi:10.5772/1963 · Cited by 59 · see citing works

−374T/A polymorphism of the RAGE gene promoter in relation to severity of coronary atherosclerosis

Falcone, C., Campo, I., Emanuele, E., Buzzi, M. P., Geroldi, D., Belvito, C., Zorzetto, M., Sbarsi, I., & Cuccia, M. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.11.021 · Cited by 60 · see citing works

Developmental expression of receptor for advanced glycation end products (RAGE), amphoterin and sulfoglucuronyl (HNK‐1) carbohydrate in mouse cerebellum and their role in neurite outgrowth and cell migration

Chou, D. K. H., Zhang, J., Smith, F. I., McCaffery, P. J. A., & Jungalwala, F. B. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02609.x · Cited by 60 · see citing works

Vitamin A (retinol) downregulates the receptor for advanced glycation endproducts (RAGE) by oxidant-dependent activation of p38 MAPK and NF-kB in human lung cancer A549 cells

Pasquali, M. A. D. B., Gelain, D. P., Zeidán‐Chuliá, F., Pires, A. S., Gasparotto, J., Terra, S. R., & Moreira, J. C. F. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.01.013 · Cited by 59 · see citing works

The biology of the receptor for advanced glycation end products and its ligands

Schmidt, A. M., Yan, S. D., Yan, S. F., & Stern, D. M. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00087-2 · Cited by 687 · see citing works

RAGE: A Multiligand Receptor Contributing to the Cellular Response in Diabetic Vasculopathy and Inflammation

Schmidt, A.-M., Hofmann, M. A., Taguchi, A., Yan, S. D., & Stern, D. M. (2000) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2000-13204 · Cited by 134 · see citing works

Receptor for age (RAGE) is a gene within the major histocompatibility class III region: implications for host response mechanisms in homeostasis and chronic disease

Schmidt, A. M. (2001) · Frontiers in bioscience · doi:10.2741/schmidt · Cited by 81 · see citing works

Understanding RAGE, the receptor for advanced glycation end products

Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M., & Nawroth, P. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0688-7 · Cited by 1,297 · see citing works

Tempering the wrath of RAGE: An emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation

Yan, S. F., Yan, S. D., Ramasamy, R., & Schmidt, A. M. (2009) · Annals of Medicine · doi:10.1080/07853890902806576 · Cited by 133 · see citing works